RP-6306
Lunresertib (RP-6306) is an orally bioavailable, selective PKMYT1 inhibitor with 14 nM potency. It demonstrates robust antitumor activity in preclinical models, particularly against CCNE1-amplified cancers, supporting its investigation in oncology research for targeted therapeutic strategies.
Product Specifications
CAS Number
2719793-90-3
Product Name Alternative
(S) -RP-6306, RP 6306, RP6306, RP-6306, PKMYT1
Field of Research
Cell Biology
Purity
98.41% (May vary between batches)
Solubility
DMSO:67.3 mg/mL (207.47 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.17 mM)
Smiles
NC=1N (C=2C (C1C (N) =O) =CC (C) =C (C) N2) C3=C (C) C (O) =CC=C3C
Molecular Formula
C18H20N4O2
Molecular Weight
324.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
32317121 3x 1.0µg DNA
Nup153 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 